Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
03/26/2014 | CN102675621B Poloxamer-niacin prodrug and preparation method thereof |
03/26/2014 | CN102618413B Production method of traditional Chinese medicine alcoholic drink |
03/26/2014 | CN102600124B Omega-3 enhanced composition and application thereof |
03/26/2014 | CN102504005B Compound with novel structure and preparation method and applications thereof |
03/26/2014 | CN102372730B Bridged ring substituted phosphodiesterase inhibitor |
03/26/2014 | CN102151281B Flavonoid compound for preventing and treating diabetes and medicament application thereof |
03/26/2014 | CN102112134B Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity |
03/26/2014 | CN102018699B Application of Xyloketal B in preparing antiatherosclerotic medicaments |
03/26/2014 | CN101953862B Extracts of eleutherococcus spp., preparation process thereof and use of the same |
03/26/2014 | CN101663262B N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
03/26/2014 | CN101568552B Collagen peptide composition and food or beverage containing the same |
03/25/2014 | US8680301 Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same |
03/25/2014 | US8680089 Fused pyridine derivatives |
03/25/2014 | US8680049 Glucagon analogues |
03/25/2014 | US8679531 Vesicle compositions |
03/25/2014 | DE202014101180U1 Zusammensetzung zur Senkung des Blutdrucks, des Blutfettspiegels und des Blutzuckerspiegels Composition for lowering blood pressure, blood lipid levels and blood sugar levels |
03/25/2014 | CA2673592C Methods for the treatment of il-1.beta. related diseases |
03/25/2014 | CA2656003C Fused cyclic compounds |
03/25/2014 | CA2531020C Cannabinoid receptor modulator |
03/25/2014 | CA2521149C Annatto extract compositions, including geranyl geraniols and methods of use |
03/25/2014 | CA2434672C Sfrp and peptide motifs that interact with sfrp and methods of their use |
03/20/2014 | WO2014043706A1 Method of synthesizing thyroid hormone analogs and polymorphs thereof |
03/20/2014 | WO2014043647A1 Therapeutic compositions and associated methods |
03/20/2014 | WO2014042939A1 Ketone linked benzothiazole inhibitors of endothelial lipase |
03/20/2014 | WO2014041885A1 Cholecystokinin secretion-promoting composition |
03/20/2014 | WO2014041111A1 Usp30 inhibitors and methods of use |
03/20/2014 | WO2014040938A1 Non-annulated thiophenylamides as inhibitors of fatty acid binding proteini(fabp) 4 and/or 5 |
03/20/2014 | WO2014040476A1 Process for synthesising brominated eneyne compound e, e-22-bromo-9,11,19-triyne-17,21-diene docosanoic acid ester |
03/20/2014 | WO2014040228A1 Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
03/20/2014 | WO2014018763A3 Method of treating type i diabetes using apolipoprotein aiv |
03/20/2014 | WO2014013505A3 Amorphous vildagliptin |
03/20/2014 | US20140080887 Methods for improving linear growth response in children |
03/19/2014 | EP2708550A1 Preparation method for insulin glargine crystal |
03/19/2014 | EP2708540A1 Pyrimido-diazepinone compound |
03/19/2014 | EP2708233A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases |
03/19/2014 | EP2707029A1 Methods of treating or preventing cholesterol related disorders |
03/19/2014 | EP2707017A1 Lixisenatide and metformin for treatment of diabetes type 2 |
03/19/2014 | EP2707016A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
03/19/2014 | EP2707015A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes |
03/19/2014 | CN103649127A Compositions, uses and methods for treatment of metabolic disorders and diseases |
03/19/2014 | CN103649090A Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof |
03/19/2014 | CN103649066A 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof |
03/19/2014 | CN103649059A 5-membered ring aromatic heterocyclic derivative having NPY Y5 receptor antagonistic activity |
03/19/2014 | CN103649055A Method for manufacturing pyrazole derivative |
03/19/2014 | CN103649053A Aminomethyl quinolone compounds |
03/19/2014 | CN103649033A Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars |
03/19/2014 | CN103648531A Method for prevention or treatment of metabolic syndrome |
03/19/2014 | CN103648520A Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
03/19/2014 | CN103648519A Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
03/19/2014 | CN103648504A Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome |
03/19/2014 | CN103648497A Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance |
03/19/2014 | CN103648495A Method of treating atherosclerosis in high triglyceride subjects |
03/19/2014 | CN103648494A DHA and EPA in the reduction of oxidative stress |
03/19/2014 | CN103648492A Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |
03/19/2014 | CN103648306A Serum cholesterol lowering drink and an improved method for lowering cholesterol |
03/19/2014 | CN103648281A Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |
03/19/2014 | CN103642716A Lactobacillus plantarum and application thereof |
03/19/2014 | CN103642663A Healthcare vinegar |
03/19/2014 | CN103642654A Production process of salvia miltiorrhiza wine |
03/19/2014 | CN103641907A Glucagon/glp-1 receptor co-agonists |
03/19/2014 | CN103641906A Glucose-dependent insulinotropic polypeptide analogues |
03/19/2014 | CN103641889A Hypoglycemic peptide and drug use thereof |
03/19/2014 | CN103641888A Multifunctional novel small peptide, composition including same and application of small peptide |
03/19/2014 | CN103641882A Novel 2,3-dihydroxyl-30-noroleanolic acid as well as preparation method and application thereof in preparing glycosidase inhibitor medicament |
03/19/2014 | CN103641875A Preparation process and quality detection method of polysaccharide-iron complex |
03/19/2014 | CN103641871A Macrocyclic polyphenol compound, and preparation and application thereof in pharmacy |
03/19/2014 | CN103641853A Preparation method for crystal of Schiff base vanadyl complex with biological activity |
03/19/2014 | CN103641841A Sesquiterpene lactone compounds as well as preparation method and application thereof |
03/19/2014 | CN103641829A Triazole derivatives as kinase inhibitors |
03/19/2014 | CN103641823A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
03/19/2014 | CN103641818A Novel crystal form of tandospirone citrate, preparation method and applications |
03/19/2014 | CN103641817A Novel crystal form of tandospirone citrate, preparation method and applications |
03/19/2014 | CN103641807A Extraction method of apigenin, pharmaceutical composition for treating diabetes and application thereof |
03/19/2014 | CN103641764A Pharmaceutical composition for regulating blood lipid |
03/19/2014 | CN103638529A Preparation method of medicament for enriching blood |
03/19/2014 | CN103638403A Medicine for treating diabetic gangrene and preparation method of medicine |
03/19/2014 | CN103638395A Traditional Chinese medicine tablet for regulating blood sugar and preparation method thereof |
03/19/2014 | CN103638389A Traditional Chinese medicine composition for treating diabetes |
03/19/2014 | CN103638358A Medicinal composition for improving glucose tolerance of patient and application thereof |
03/19/2014 | CN103638340A Multiflower knotweed root Chinese medicinal potion |
03/19/2014 | CN103638329A Medicine for treating diabetes mellitus and preparation method of medicine |
03/19/2014 | CN103638302A Medicine for treating hyperlipemia |
03/19/2014 | CN103638282A Method for preparation of fat-reducing preparation from pure traditional Chinese medicines |
03/19/2014 | CN103638261A Composite Chinese medicinal herb formula |
03/19/2014 | CN103638223A Compound preparation capsule for reducing blood fat |
03/19/2014 | CN103638198A Apocynum venetum liquor production process |
03/19/2014 | CN103638166A Weight-reducing oil |
03/19/2014 | CN103638089A Method for extracting alpha-amylase inhibitor from white kidney beans by use of microwave-compound enzyme coupling method |
03/19/2014 | CN103638081A Pharmaceutical composition used for preventing diabetic retinopathy |
03/19/2014 | CN103638078A Method for preparing panax notoginseng saponins matrix type sustained release tablet |
03/19/2014 | CN103638073A Application of penthorum Chinese pursh extract in preparation of hypoglycemic drugs |
03/19/2014 | CN103638069A Electrolyte supplement for treating calf diarrhoea and application method |
03/19/2014 | CN103638031A Preparation method of compound quinatic acid and application in preparation of glycosidase inhibitor medicine |
03/19/2014 | CN103638018A Compound amino acid injection 18AA-VII pharmaceutical composition and preparation method thereof |
03/19/2014 | CN103638006A Application of Oleaceran in medicine for lowering blood glucose |
03/19/2014 | CN103637999A Multi-layer solid drug dosage form |
03/19/2014 | CN103637995A Vitamin C tablets and preparation method |
03/19/2014 | CN103637984A Baicalin nanometer crystal and preparation method thereof |
03/19/2014 | CN103637974A Preparation method of weight-reducing bath bag |
03/19/2014 | CN103637325A Healthcare strawberry juice |